why choose us

First received: November 29, 2022

Clinical Trial: Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pleural Biphasic Mesothelioma

Study Type: INTERVENTIONAL


Official Title: Official Title Neoadjuvant Immunotherapy in Sarcomatoid Mesothelioma

Brief Summary: This phase II trial evaluates the safety and effectiveness of giving immunotherapy (nivolumab and ipilimumab) before surgery for controlling disease in patients with stage I-IIIa sarcomatoid mesothelioma.Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.Giving immunotherapy before surgery may be more effective at controlling disease in patients with sarcomatoid…

Read more